Survey reveals primary care providers want more patients to talk to them about mental health

Open communication between provider and patient is important amid the mental health epidemic and shortage of mental health specialists

Image Downloads

(MASON, Ohio) – Anxiety and depression continue to plague the nation following the COVID-19 pandemic, with more than 40 percent of adults reporting recent symptoms of anxiety or depression. A shortage of mental health professionals has put Primary Care Providers (PCPs) on the front line of defense for their patients’ mental health issues. But a new national survey of PCPs by the GeneSight Mental Health Monitor finds 83 percent wish more of their patients would talk to them about their mental health concerns and more than half don’t believe patients know that PCPs are fully trained and equipped to diagnose and treat mental health conditions.

Regular mental health screenings at primary care appointments are the first step in bridging this communication gap and accurately diagnosing those suffering with anxiety, depression, ADHD and other mental health conditions. However, diagnosis is just the first step in what is often an uphill battle to find the right medications and dosage to effectively alleviate patients’ symptoms. 

Michele Long, a nurse practitioner in Lancaster, Ohio, uses the GeneSight test to reduce the mental health medication trial-and-error process, which provides her with a report indicating FDA-approved medications and dosages that are more likely to be effective based on a patient’s genetic information.

“Finding effective treatment can be a very frustrating process for patients and they often feel defeated when a medication fails,” Long said. “The GeneSight test takes a lot of the guesswork out of the process so I can help them feel better sooner. It’s a valuable tool that helps me find solutions for those who have entrusted me with caring for their mental health.”

“There’s a communication gap between the patient and the clinician. PCPs are looking to their patients to bring up their mental health issues, and patients are looking for their providers to recognize their mental health challenges,” said Fred Fantazzia, general manager of Myriad Mental Health, makers of the GeneSight test. “Opening those lines of communication is critical as more people experience mental health issues and there are fewer mental health specialists to treat them.”

Despite the success that those like Long have seen in patients using the GeneSight test, the survey found that less than one in five PCPs use available genetic tests to help inform their mental health medication treatment plans.


(click to download)

Michele Long (left) is a primary care nurse practitioner who makes a point of screening for depression and discussing mental health with all of her patients. The GeneSight Mental Health Monitor finds that more than half of primary care physicians surveyed believe their patients are unaware that they are trained and equipped to diagnose and treat mental health conditions.

As a primary care provider, Michele Long makes a point to screen every patient for mental health conditions. Long uses the GeneSight test to make informed decisions about mental health medications and doses that may be more likely to be effective for a patient based on their genetic information.

The GeneSight test helps providers make decisions on mental health medications and doses that may be more likely to help patients suffering from anxiety, depression, ADHD and other mental health conditions based on their unique genetic information.

Michele Long (right) reviews a GeneSight test report with her patient, Beth. Genetic information helps providers find effective mental health medications and may reduce the frustrating trial-and-error process that is common when treating mental illness.

Michele Long conducts a GeneSight test on a patient diagnosed with depression. With a simple cheek swab, the test provides clinicians with a patient’s unique genetic information that indicates which medications may require dose adjustments, be less likely to work, or have an increased risk of side effects.

Your file is downloading.